Recognition and signaling by toll-like receptors

Annual Review of Cell and Developmental Biology

Volumn 22, Issue , 2006, Pages 409-437

  West, A Phillip ^a   Koblansky, Anna Alicia ^a   Ghosh, Sankar ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Innate immunity; Leucine rich repeat; MyD88; Signal transaction; TIR domain; TRIF

Indexed keywords

LEUCINE; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9;

BACTERIAL INFECTION; BINDING SITE; ENZYME ACTIVITY; IMMUNE SYSTEM; INFLAMMATION; INNATE IMMUNITY; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; REVIEW; SIGNAL TRANSDUCTION; VIRUS INFECTION;

ANIMALS; HUMANS; LIGANDS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 33751172758     PISSN: 10810706     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.cellbio.21.122303.115827     Document Type: Review

References (171)

1. Adachi O, Kawai T, Takeda K, Matsumoto M, Tsutsui H, et al. 1998. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9:143-50
2. Akira S, Takeda K. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4:499-511
3. Akira S, Takeda K, Kaisho T. 2001. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2:675-80
4. Albrecht I, Tapmeier T, Zimmermann S, Frey M, Heeg K, Dalpke A. 2004. Toll-like receptors differentially induce nucleosome remodelling at the IL-12p40 promoter. EMBO Rep. 5:172-77
5. Alexander WS. 2002. Suppressors of cytokine signalling (SOCS) in the immune system. Nat. Rev. Immunol. 2:410-16
6. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. 2001. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413:732-38
7. Andrejeva J, Childs KS, Young DF, Carlos TS, Stock N, et al. 2004. The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-β promoter. Proc. Natl. Acad. Sci. USA 101:17264-69
8. Baetz A, Frey M, Heeg K, Dalpke AH. 2004. Suppressor of cytokine signaling (SOCS) proteins indirectly regulate toll-like receptor signaling in innate immune cells. J. Biol. Chem. 279:54708-15
9. Barton GM, Kagan JC, Medzhitov R. 2006. Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat. Immunol. 7:49-56
10. Bell JK, Botos I, Hall PR, Askins J, Shiloach J, et al. 2005. The molecular structure of the Toll-like receptor 3 ligand-binding domain. Proc. Natl. Acad. Sci. USA 102:10976-80
11. Bell JK, Mullen GE, Leifer CA, Mazzoni A, Davies DR, Segal DM. 2003. Leucine-rich repeats and pathogen recognition in Toll-like receptors. Trends Immunol. 24:528-33
12. Beutler B. 2004. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 430:257-63
13. Beutler B, Hoebe K, Georgel P, Tabeta K, Du X. 2005. Genetic analysis of innate immunity: identification and function of the TIR adapter proteins. Adv. Exp. Med. Biol. 560:29-39
14. Brint EK, Xu D, Liu H, Dunne A, McKenzie AN, et al. 2004. ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance. Nat. Immunol. 5:373-79
15. Brown GD, Gordon S. 2001. Immune recognition. A new receptor for beta-glucans. Nature 413:36-37
16. Brown GD, Herre J, Williams DL, Willment JA, Marshall AS, Gordon S. 2003. Dectin-1 mediates the biological effects of beta-glucans. J. Exp. Med. 197:1119-24
17. Bulut Y, Faure E, Thomas L, Equils O, Arditi M. 2001. Cooperation of Toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling. J. Immunol. 167:987-94
18. Burns K, Clatworthy J, Martin L, Martinon F, Plumpton C, et al. 2000. Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor. Nat. Cell. Biol. 2:346-51
19. Burns K, Janssens S, Brissoni B, Olivos N, Beyaert R, Tschopp J. 2003. Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4. J. Exp. Med. 197:263-68
20. Campos MA, Almeida IC, Takeuchi O, Akira S, Valente EP, et al. 2001. Activation of Toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite. J. Immunol. 167:416-23
21. Chen G, Goeddel DV. 2002. TNF-R1 signaling: a beautiful pathway. Science 296:1634-33
22. Chen ZJ. 2005. Ubiquitin signalling in the NF-κB pathway. Nat. Cell. Biol. 7:758-65
23. Choe J, Kelker MS, Wilson IA. 2005. Crystal structure of human toll-like receptor 3 (TLR3) ectodomain. Science 309:581-85
24. Coban C, Ishii KJ, Kawai T, Hemmi H, Sato S, et al. 2005. Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin. J. Exp. Med. 201:19-25
25. Covert MW, Leung TH, Gaston JE, Baltimore D. 2005. Achieving stability of lipopolysaccharide-induced NF-kappaB activation. Science 309:1854-57
26. Cusson-Hermance N, Lee TH, Fitzgerald KA, Kelliher MA. 2005. Rip1 mediates the Trif-dependent Toll-like receptor 3 and 4-induced NF-κ B activation but does not contribute to IRF-3 activation. J. Biol. Chem, 280:36560-66
27. Deng L, Wang C, Spencer E, Yang L, Braun A, et al. 2000. Activation of the IκB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103:351-61
28. Didierlaurent A, Brissoni B, Velin D, Aebi N, Tardivel A, et al. 2006. Tollip regulates proinflammatory responses to interleukin-1 and lipopolysaccharide. Mol. Cell. Biol. 26:735-42
29. Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C. 2004. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303:1529-31
30. Fitzgerald KA, McWhirter SM, Faia KL, Rowe DC, Latz E, et al. 2003a. IKKε and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4:491-96
31. Fitzgerald KA, Palsson-McDermott EM, Bowie AG, Jefferies CA, Mansell AS, et al. 2001. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature 413:78-83
32. Fitzgerald KA, Rowe DC, Barnes BJ, Caffrey DR, Visintin A, et al. 2003b. LPS-TLR4 signaling to IRF-3/7 and NF-κB involves the Toll adapters TRAM and TRIF. J. Exp. Med. 198:1043-55
33. Franchi L, Amer A, Body-Malapel M, Kanneganti TD, Ozoren N, et al. 2006. Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1 β in salmonella-infected macrophages. Nat. Immunol. 7:576-82
34. Garlanda C, Riva F, Polentarutti N, Buracchi C, Sironi M, et al. 2004. Intestinal inflammation in mice deficient in Tir8, an inhibitory member of the IL-1 receptor family. Proc. Natl. Acad. Sci. USA 101:3522-26
35. Gilchrist M, Thorsson V, Li B, Rust AG, Korb M, et al. 2006. Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4. Nature 441:173-78
36. Gingras S, Parganas E, de Pauw A, Ihle JN, Murray PJ. 2004. Re-examination of the role of suppressor of cytokine signaling 1 (SOCS1) in the regulation of Toll-like receptor signaling. J. Biol. Chem. 279:54702-7
37. Gohda J, Matsumura T, Inoue J. 2004. Cutting edge: TNFR-associated factor (TRAF) 6 is essential for MyD88-dependent pathway but not Toll/IL-1 receptor domain-containing adaptor-inducing IFN-β (TRIF)-dependent pathway in TLR signaling. J. Immunol. 173:2913-17
38. Grabiec A, Meng G, Fichte S, Bessler W, Wagner H, Kirschning CJ. 2004. Human but not murine Toll-like receptor 2 discriminates between tri-palmitoylated and tri-lauroylated peptides. J. Biol. Chem. 279:48004-12
39. Hacker H, Redecke V, Blagoev B, Kratchmarova I, Hsu LC, et al. 2006. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature 439:204-7
40. Hajishengallis G, Tapping RI, Martin MH, Nawar H, Lyle EA, et al. 2005. Toll-like receptor 2 mediates cellular activation by the B subunits of type II heat-labile enterotoxins. Infect. Immunol. 73:1343-49
41. Hayashi F, Smith KD, Ozinsky A, Hawn TR, Yi EC, et al. 2001. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410:1099-103
42. Hayden MS, Ghosh S. 2004. Signaling to NF-κB. Genes Dev. 18:2195-224
43. Haziot A, Ferrero E, Kontgen F, Hijiya N, Yamamoto S, et al. 1996. Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. Immunity 4:407-14
44. Heil F, Ahmad-Nejad P, Hemmi H, Hochrein H, Ampenberger F, et al. 2003. The Toll-like receptor 7 (TLR7)-specific stimulus loxoribine uncovers a strong relationship within the TLR7, 8 and 9 subfamily. Eur. J. Immunol. 33:2987-97
45. Hemmi H, Kaisho T, Takeuchi O, Sato S, Sanjo H, et al. 2002. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat. Immunol. 3:196-200
46. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, et al. 2000. A Toll-like receptor recognizes bacterial DNA. Nature 408:740-45
47. Hemmi H, Takeuchi O, Sato S, Yamamoto M, Kaisho T, et al. 2004. The roles of two IκB kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection. J. Exp. Med. 199:1641-50
48. Hoebe K, Du X, Georgel P, Janssen E, Tabeta K, et al. 2003. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 424:743-48
49. Hoebe K, Georgel P, Rutschmann S, Du X, Mudd S, et al. 2005. CD36 is a sensor of diacylglycerides. Nature 433:523-27
50. Hoffmann JA, Kafatos FC, Janeway CA Jr, Ezekowitz RAB. 1999. Phylogenetic perspectives in innate immunity. Science 284:1313-18
51. Honda K, Sakaguchi S, Nakajima C, Watanabe A, Yanai H, et al. 2003. Selective contribution of IFN-α/β signaling to the maturation of dendritic cells induced by double-stranded RNA or viral infection. Proc. Natl. Acad. Sci. USA 100:10872-77
52. Honda K, Yanai H, Negishi H, Asagiri M, Sato M, et al. 2005. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434:772-77
53. Horng T, Barton GM, Flavell RA, Medzhitov R. 2002. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors. Nature 420:329-33
54. Horng T, Barton GM, Medzhitov R. 2001. TIRAP: an adapter molecule in the Toll signaling pathway. Nat. Immunol. 2:835-41
55. Hoshino K, Kaisho T, Iwabe T, Takeuchi O, Akira S. 2002. Differential involvement of IFN-β in Toll-like receptor-stimulated dendritic cell activation. Int. Immunol. 14:1225-31
56. Hoshino K, Sugiyama T, Matsumoto M, Tanaka T, Saito M, et al. 2006. IκB kinase-α is critical for interferon-α production induced by Toll-like receptors 7 and 9. Nature 440:949-53
57. Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, et al. 1999. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162:3749-52
58. Huang Q, Yang J, Lin Y, Walker C, Cheng J, et al. 2004. Differential regulation of interleukin 1 receptor and Toll-like receptor signaling by MEKK3. Nat. Immunol. 5:98-103
59. Ishii KJ, Coban C, Kato H, Takahashi K, Torii Y, et al. 2006. A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA. Nat. Immunol. 7:40-48
60. Iwaki D, Mitsuzawa H, Murakami S, Sano H, Konishi M, et al. 2002. The extracellular Toll-like receptor 2 domain directly binds peptidoglycan derived from Staphylococcus aureus. J. Biol. Chem. 277:24315-20
61. Izaguirre A, Barnes BJ, Amrute S, Yeow WS, Megjugorac N, et al. 2003. Comparative analysis of IRF and IFN-α expression in human plasmacytoid and monocyte-derived dendritic cells. J. Leukoc. Biol. 74:1125-38
62. Janeway CA Jr. 1989. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb. Symp. Quant. Biol. 54(Pt. 1):1-13
63. Jurk M, Heil F, Vollmer J, Schetter C, Krieg AM, et al. 2002. Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848. Nat. Immunol. 3:499
64. Kaisho T, Takeuchi O, Kawai T, Hoshino K, Akira S. 2001. Endotoxin-induced maturation of MyD88-deficient dendritic cells. J. Immunol. 166:5688-94
65. Kariko K, Buckstein M, Ni H, Weissman D. 2005. Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity 23:165-75
66. Karin M, Ben-Neriah Y. 2000. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu. Rev. Immunol. 18:621-63
67. Kataoka K, Muta T, Yamazaki S, Takeshige K. 2002. Activation of macrophages by linear (1 → 3)-β-D-glucans. Implications for the recognition of fungi by innate immunity. J. Biol. Chem. 277:36825-31
68. Kato H, Sato S, Yoneyama M, Yamamoto M, Uematsu S, et al. 2005. Cell type-specific involvement of RIG-I in antiviral response. Immunity 23:19-28
69. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, et al. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101-5
70. Kawai T, Adachi O, Ogawa T, Takeda K, Akira S. 1999. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11:115-22
71. Kawai T, Sato S, Ishii KJ, Coban C, Hemmi H, et al. 2004. Interferon-α induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat. Immunol. 5:1061-68
72. Kawai T, Takahashi K, Sato S, Coban C, Kumar H, et al. 2005. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat. Immunol. 6:981-88
73. Kawai T, Takeuchi O, Fujita T, Inoue J, Muhlradt PF, et al. 2001. Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J. Immunol. 167:5887-94
74. Kerkmann M, Rothenfusser S, Hornung V, Towarowski A, Wagner M, et al. 2003. Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cells. J. Immunol. 170:4465-74
75. Kinjyo I, Hanada T, Inagaki-Ohara K, Mori H, Aki D, et al. 2002. SOCS1/JAB is a negative regulator of LPS-induced macrophage activation. Immunity 17:583-91
76. Kobayashi K, Hernandez LD, Galan JE, Janeway CA Jr, Medzhitov R, Flavell RA. 2002. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 110:191-202
77. Kobe B, Kajava AV. 2001. The leucine-rich repeat as a protein recognition motif. Curr. Opin. Struct. Biol. 11:725-32
78. Kopp E, Medzhitov R, Carothers J, Xiao C, Douglas I, et al. 1999. ECSIT is an evolutionarily conserved intermediate in the Toll/IL-1 signal transduction pathway. Genes Dev. 13:2059-71
79. Krug A, Luker GD, Barchet W, Leib DA, Akira S, Colonna M. 2004. Herpes simplex virus type 1 activates murine natural interferon-producing cells through Toll-like receptor 9. Blood 103:1433-37
80. Kurt-Jones EA, Popova L, Kwinn L, Haynes LM, Jones LP, et al. 2000. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat. Immunol. 1:398-401
81. Leadbetter EA, Rifkin IR, Hohlbaum AM, Beaudette BC, Shlomchik MJ, Marshak-Rothstein A. 2002. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416:603-7
82. Lee HK, Dunzendorfer S, Soldau K, Tobias PS. 2006. Double-stranded RNA-mediated TLR3 activation is enhanced by CD14. Immunity 24:153-63
83. Lee JH, Voo KS, Skalnik DG. 2001. Identification and characterization of the DNA binding domain of CpG-binding protein. J. Biol. Chem. 276:44669-76
84. Lemaitre B, Nicolas E, Michaut L, Reichhart JM, Hoffmann JA. 1996. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86:973-83
85. Lien E, Means TK, Heine H, Yoshimura A, Kusumoto S, et al. 2000. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J. Clin. Invest. 105:497-504
86. Liew FY, Xu D, Brint EK, O'Neill LA. 2005. Negative regulation of Toll-like receptor-mediated immune responses. Nat. Rev. Immunol. 5:446-58
87. Lund J, Sato A, Akira S, Medzhitov R, Iwasaki A. 2003. Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J. Exp. Med. 198:513-20
88. Lund JM, Alexopoulou L, Sato A, Karow M, Adams NC, et al. 2004. Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc. Natl. Acad. Sci. USA 101:5598-603
89. Mambula SS, Sau K, Henneke P, Golenbock DT, Levitz SM. 2002. Toll-like receptor (TLR) signaling in response to Aspergillus fumigatus. J. Biol. Chem. 277:39320-26
90. Mansell A, Brint E, Gould JA, O'Neill LA, Hertzog PJ. 2004. Mal interacts with tumor necrosis factor receptor-associated factor (TRAF)-6 to mediate NF-κB activation by Toll-like receptor (TLR)-2 and TLR4-7. J. Biol. Chem. 279:37227-30
91. Mansell A, Smith R, Doyle SL, Gray P, Fenner JE, et al. 2006. Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation. Nat. Immunol. 7:148-55
92. Massari P, Henneke P, Ho Y, Latz E, Golenbock DT, Wetzler LM. 2002. Cutting edge: immune stimulation by neisserial porins is Toll-like receptor 2 and MyD88 dependent. J. Immunol. 168:1533-37
93. McWhirter SM, Fitzgerald KA, Rosains J, Rowe DC, Golenbock DT, Maniatis T. 2004. IFN-regulatory factor 3-dependent gene expression is defective in Tbk1-deficient mouse embryonic fibroblasts. Proc. Natl. Acad. Sci. USA 101:233-38
94. Means TK, Wang S, Lien E, Yoshimura A, Golenbock DT, Fenton MJ. 1999. Human Toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J. Immunol. 163:3920-27
95. Medzhitov R, Janeway CA Jr. 1997. Innate immunity: the virtues of a nonclonal system of recognition. Cell. 91:295-98
96. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr. 1997. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388:394-97
97. Medzhitov R, Preston-Hurlburt P, Kopp E, Stadlen A, Chen C, et al. 1998. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol. Cell 2:253-58
98. Medzhitov RJ, Janeway CA Jr. 2001. Innate immunity: the virtues of a nonclonal system of recognition. Cell. 91:295-98
99. Meng G, Grabiec A, Vallon M, Ebe B, Hampel S, et al. 2003. Cellular recognition of tri-/dipalmitoylated peptides is independent from a domain encompassing the N-terminal seven leucine-rich repeat (LRR)/LRR-like motifs of TLR2. J. Biol. Chem. 278:39822-29
100. Meylan E, Burns K, Hofmann K, Blancheteau V, Martinon F, et al. 2004. RIP1 is an essential mediator of Toll-like receptor 3-induced NF-κB activation. Nat. Immunol. 5:503-7
101. Meylan E, Curran J, Hofmann K, Moradpour D, Binder M, et al. 2005. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437:1167-72
102. Miao EA, Alpuche-Aranda CM, Dors M, Clark AE, Bader MW, et al. 2006. Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1β via Ipaf. Nat. Immunol. 7:569-75
103. Mitsuzawa H, Wada I, Sano H, Iwaki D, Murakami S, et al. 2001. Extracellular Toll-like receptor 2 region containing Ser40-Ile64 but not Cys30-Ser39 is critical for the recognition of Staphylococcus aureus peptidoglycan. J. Biol. Chem. 276:41350-56
104. Miyake K. 2004. Innate recognition of lipopolysaccharide by Toll-like receptor 4-MD-2. Trends Microbiol. 12:186-92
105. Mizel SB, Honko AN, Moors MA, Smith PS, West AP. 2003a. Induction of macrophage nitric oxide production by Gram-negative flagellin involves signaling via heteromeric Toll-like receptor 5/Toll-like receptor 4 complexes. J. Immunol. 170:6217-23
106. Mizel SB, West AP, Hantgan RR. 2003b. Identification of a sequence in human Toll-like receptor 5 required for the binding of Gram-negative flagellin. J. Biol. Chem. 278:23624-29
107. Muzio M, Ni J, Feng P, Dixit VM. 1997. IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science 278:1612-15
108. Nagai Y, Akashi S, Nagafuku M, Ogata M, Iwakura Y, et al. 2002. Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat. Immunol. 3:667-72
109. Nakagawa R, Naka T, Tsutsui H, Fujimoto M, Kimura A, et al. 2002. SOCS-1 participates in negative regulation of LPS responses. Immunity 17:677-87
110. Oganesyan G, Saha SK, Guo B, He JQ, Shahangian A, et al. 2006. Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response. Nature 439:208-11
111. Omueti KO, Beyer JM, Johnson CM, Lyle EA, Tapping RI. 2005. Domain exchange between human Toll-like receptors 1 and 6 reveals a region required for lipopeptide discrimination. J. Biol. Chem. 280:36616-25
112. Oshiumi H, Matsumoto M, Funami K, Akazawa T, Seya T. 2003a. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction. Nat. Immunol. 4:161-67
113. Oshiumi H, Sasai M, Shida K, Fujita T, Matsumoto M, Seya T. 2003b. TIR-containing adapter molecule (TICAM)-2, a bridging adapter recruiting to Toll-like receptor 4 TICAM-1 that induces Interferon-β. J. Biol. Chem. 278:49751-62
114. Ozinsky A, Underhill DM, Fontenot JD, Hajjar AM, Smith KD, et al. 2000. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors. Proc. Natl. Acad. Sci. USA 97:13766-71
115. Perera PY, Mayadas TN, Takeuchi O, Akira S, Zaks-Zilberman M, et al. 2001. CD11b/CD18 acts in concert with CD14 and Toll-like receptor (TLR) 4 to elicit full lipopolysaccharide and taxol-inducible gene expression. J. Immunol. 166:574-81
116. Perry AK, Chow EK, Goodnough JB, Yeh WC, Cheng G. 2004. Differential requirement for TANK-binding kinase-1 in type I Interferon responses to Toll-like receptor activation and viral infection. J. Exp. Med. 199:1651-58
117. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, et al. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282:2085-88
118. Poltorak A, Ricciardi-Castagnoli P, Citterio S, Beutler B. 2000. Physical contact between lipopolysaccharide and Toll-like receptor 4 revealed by genetic complementation. Proc. Natl. Acad. Sci. USA 97:2163-67
119. Rowe DC, McGettrick AF, Latz E, Monks BG, Gay NJ, et al. 2006. The myristoylation of TRIF-related adaptor molecule is essential for Toll-like receptor 4 signal transduction. Proc. Natl. Acad. Sci. USA 103:6299-304
120. Sato M, Suemori H, Hata N, Asagiri M, Ogasawara K, et al. 2000. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-α/β gene induction. Immunity 13:539-48
121. Sato S, Sanjo H, Takeda K, Ninomiya-Tsuji J, Yamamoto M, et al. 2005. Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat. Immunol. 6:1087-95
122. Sato S, Sugiyama M, Yamamoto M, Watanabe Y, Kawai T, et al. 2003. Toll/IL-1 receptor domain-containing adaptor inducing IFN-β (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-κ B and IFN-regulatory factor-3, in the Toll-like receptor signaling. J. Immunol. 171:4304-10
123. Schoenemeyer A, Barnes BJ, Mancl ME, Latz E, Goutagny N, et al. 2005. The interferon regulatory factor, IRF5, is a central mediator of Toll-like receptor 7 signaling. J. Biol. Chem. 280:17005-12
124. Sellati TJ, Bouis DA, Kitchens RL, Darveau RP, Pugin J, et al. 1998. Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytic cells via a CD14-dependent pathway distinct from that used by lipopolysaccharide. J. Immunol. 160:5455-64
125. Seth RB, Sun L, Ea CK, Chen ZJ. 2005. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-κB and IRF 3. Cell 122:669-82
126. Shibuya H, Yamaguchi K, Shirakabe K, Tonegawa A, Gotoh Y, et al. 1996. TAB1: an activator of the TAK1 MAPKKK in TGF-beta signal transduction. Science 272:1179-82
127. Shim JH, Xiao C, Paschal A, Bailey S, Rao P, et al. 2005. TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. Genes Dev. 19:2668-81
128. Shimazu R, Akashi S, Ogata H, Nagai Y, Fukudome K, et al. 1999. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 189:1777-82
129. Shoham S, Huang C, Chen JM, Golenbock DT, Levitz SM. 2001. Toll-like receptor 4 mediates intracellular signaling without TNF-α release in response to Cryptococcus neoformans polysaccharide capsule. J. Immunol. 166:4620-26
130. Silverstein AM. 2003. Darwinism and immunology: from Metchnikoff to Burnet. Nat. Immunol. 4:3-6
131. Sing A, Rost D, Tvardovskaia N, Roggenkamp A, Wiedemann A, et al. 2002. Yersinia V-antigen exploits Toll-like receptor 2 and CD14 for interleukin 10-mediated immunosuppression. J. Exp. Med. 196:1017-24
132. Smith KD, Andersen-Nissen E, Hayashi F, Strobe K, Bergman MA, et al. 2003. Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motility. Nat. Immunol. 4:1247-53
133. Stetson DB, Medzhitov R. 2006. Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity 24:93-103
134. Sun L, Deng L, Ea CK, Xia ZP, Chen ZJ. 2004. The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. Mol. Cell. 14:289-301
135. Sun Q, Sun L, Liu HH, Chen X, Seth RB, et al. 2006. The specific and essential role of MAVS in antiviral innate immune responses. Immunity 24:633-42
136. Suzuki N, Suzuki S, Duncan GS, Millar DG, Wada T, et al. 2002. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. Nature 416:750-56
137. Takaesu G, Kishida S, Hiyama A, Yamaguchi K, Shibuya H, et al. 2000. TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway. Mol. Cell. 5:649-58
138. Takaoka A, Yanai H, Kondo S, Duncan G, Negishi H, et al. 2005. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 434:243-49
139. Takeda K, Akira S. 2005. Toll-like receptors in innate immunity. Int. Immunol. 17:1-14
140. Takeda K, Kaisho T, Akira S. 2003. Toll-like receptors. Annu. Rev. Immunol. 21:335-76
141. Takeshita F, Leifer CA, Gursel I, Ishii KJ, Takeshita S, et al. 2001. Cutting edge: role of Toll-like receptor 9 in CpG DNA-induced activation of human cells. J. Immunol. 167:3555-58
142. Takeuchi O, Hoshino K, Akira S. 2000. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J. Immunol. 165:5392-96
143. Takeuchi O, Kawai T, Muhlradt PF, Morr M, Radolf JD, et al. 2001. Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int. Immunol. 13:933-40
144. Takeuchi O, Sato S, Horiuchi T, Hoshino K, Takeda K, et al. 2002. Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J. Immunol. 169:10-14
145. Thomassen E, Renshaw BR, Sims JE. 1999. Identification and characterization of SIGIRR, a molecule representing a novel subtype of the IL-1R superfamily. Cytokine 11:389-99
146. Uematsu S, Sato S, Yamamoto M, Hirotani T, Kato H, et al. 2005. Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-α induction. J. Exp. Med. 201:915-23
147. Ulevitch RJ. 1993. Recognition of bacterial endotoxins by receptor-dependent mechanisms. Adv. Immunol. 53:267-89
148. Underhill DM, Ozinsky A, Hajjar AM, Stevens A, Wilson CB, et al. 1999a. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 401:811-15
149. Underhill DM, Ozinsky A, Smith KD, Aderem A. 1999b. Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages. Proc. Natl. Acad. Sci. USA 96:14459-63
150. Vasselon T, Detmers PA, Charron D, Haziot A. 2004. TLR2 recognizes a bacterial lipopeptide through direct binding. J. Immunol. 173:7401-5
151. Viglianti GA, Lau CM, Hanley TM, Miko BA, Shlomchik MJ, Marshak-Rothstein A. 2003. Activation of autoreactive B cells by CpG dsDNA. Immunity 19:837-47
152. Wald D, Qin J, Zhao Z, Qian Y, Naramura M, et al. 2003. SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling. Nat. Immunol. 4:920-27
153. Wang C, Deng L, Hong M, Akkaraju GR, Inoue J, Chen ZJ. 2001. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412:346-51
154. Weinmann AS, Mitchell DM, Sanjabi S, Bradley MN, Hoffmann A, et al. 2001. Nucleosome remodeling at the IL-12 p40 promoter is a TLR-dependent, Rel-independent event. Nat. Immunol. 2:51-57
155. Werner SL, Barken D, Hoffmann A. 2005. Stimulus specificity of gene expression programs determined by temporal control of IKK activity. Science 309:1857-61
156. Wesche H, Gao X, Li X, Kirschning CJ, Stark GR, Cao Z. 1999. IRAK-M is a novel member of the Pelle/interleukin-1 receptor-associated kinase (IRAK) family. J. Biol. Chem. 274:19403-10
157. Wesche H, Henzel WJ, Shillinglaw W, Li S, Cao Z. 1997. MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity 7:837-47
158. Wetzler LM. 2003. The role of Toll-like receptor 2 in microbial disease and immunity. Vaccine 21(Suppl. 2):S55-60
159. Wooten RM, Morrison TB, Weis JH, Wright SD, Thieringer R, Weis JJ. 1998. The role of CD14 in signaling mediated by outer membrane lipoproteins of Borrelia burgdorferi. J. Immunol. 160:5485-92
160. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431-33
161. Wyllie DH, Kiss-Toth E, Visintin A, Smith SC, Boussouf S, et al. 2000. Evidence for an accessory protein function for Toll-like receptor 1 in anti-bacterial responses. J. Immunol. 165:7125-32
162. Xiao C, Shim JH, Kluppel M, Zhang SS, Dong C, et al. 2003. Ecsit is required for Bmp signaling and mesoderm formation during mouse embryogenesis. Genes Dev. 17:2933-49
163. Xu LG, Wang YY, Han KJ, Li LY, Zhai Z, Shu HB. 2005. VISA is an adapter protein required for virus-triggered IFN-β signaling. Mol. Cell 19:727-40
164. Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, et al. 2003a. Role of adaptor TRIF in the MyD88-independent Toll-like receptor signaling pathway. Science 301:640-43
165. Yamamoto M, Sato S, Hemmi H, Sanjo H, Uematsu S, et al. 2002a. Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4. Nature 420:324-29
166. Yamamoto M, Sato S, Hemmi H, Uematsu S, Hoshino K, et al. 2003b. TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat. Immunol. 4:1144-50
167. Yamamoto M, Sato S, Mori K, Hoshino K, Takeuchi O, et al. 2002b. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-β promoter in the Toll-like receptor signaling. J. Immunol. 169:6668-72
168. Yarovinsky F, Zhang D, Andersen JF, Bannenberg GL, Serhan CN, et al. 2005. TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science 308:1626-29
169. Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, et al. 2004. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5:730-37
170. Zhang D, Zhang G, Hayden MS, Greenblatt MB, Bussey C, et al. 2004. A Toll-like receptor that prevents infection by uropathogenic bacteria. Science 303:1522-26
171. Zhang G, Ghosh S. 2002. Negative regulation of toll-like receptor-mediated signaling by Tollip. J. Biol. Chem. 277:7059-65